Medicon Valley Alliance is proud to be the project managing partner for three international projects receiving grants from EU Interreg Öresund-Kattegat-Skagerrak (ÖKS).
Interreg ÖKS supports regional development projects across borders in Southern Scandinavia, within the themes of Innovation and entrepreneurship, Green transition, Transport and mobility, and Borderless labor market. The first call for applications in their new program 2021-2027 was concluded last week, and three applications where MVA is a project partner were approved: HALRIC, DiaUnion, and CINDIS – described in more detail below.
This year we celebrate that MVA was founded 25 years ago, as an Interreg-supported initiative itself. Now a thriving independent life science organization with over 300 members, we have over the years been partner in multiple Interreg cross-border projects, and we are excited to continuing that in the new program period. All three newly-approved projects will strengthen life science research and collaborations in Medicon Valley’s ecosystem, and contribute to making it the leading life science region in the European Union.
HALRIC (Hanseatic Life Science Research Infrastructure Consortium) is a 3-year initiative between Sweden, Denmark, Germany and Norway to create collaborations and innovation capacity around highly-specialized life science research infrastructures – such as ESS, MAX IV, DESY and XFEL, but also unique smaller-scale infrastructures and competences. The project aims to facilitate up to 75 pilot collaborations for companies, hospitals, and universities with research infrastructures. The consortium will also develop prototype models for handling the very large amounts of data generated by such infrastructures – and its third aim is further development of the life science ecosystems in the involved regions through virtual meeting places and an international strategic forum. The consortium will be led by Lund University and MVA, and consists of 21 partners including infrastructures, hospitals, academia, regional governments, and life science organizations.
Learn more about HALRIC
DiaUnion 1.5 is a collaboration between Lund University, Steno Diabetes Center Copenhagen and MVA for early detection of type 1 diabetes and two genetically-related autoimmune diseases (celiac disease and autoimmune thyroiditis). In DiaUnion 1.5 the screening is extended to first-degree relatives with the aim to screen a total of 4,500 people. The goals of the project are to study tracing based on first-degree relatives, improving blood sampling technology as well as multiplex screening using advanced digital technology, and importantly to develop a Genetic Risk Score for the triad of type 1 diabetes, celiac disease and autoimmune thyroiditis.
Learn more about DiaUnion
CINDIS (Consortium for Intelligent Diagnostics of Skin cancer) is a pre-project between MVA and Malmö University around the feasibility of a new noninvasive sampling and diagnostics technology in skin cancer patients. Skin cancers can be hard to diagnose accurately without biopsy or surgery, and this new method under development at Malmö University will be feasibility-tested by the project’s clinical collaborators at Lund University and at Bispebjerg Hospital. If successful, a large collaborative project will await to develop and mature the method, and validate it extensively to enable implementation in routine care.
A total list of all funded projects can be foundon the Interreg Project webpage